Wegovy vs Ozempic (2026) Updated · 14d ago
Quick answer: Wegovy and Ozempic contain the same active ingredient — semaglutide — made by Novo Nordisk. Wegovy is FDA-approved for chronic weight management (max 2.4 mg weekly). Ozempic is FDA-approved for type 2 diabetes (max 2 mg weekly). Different brand, different indication, same molecule.
Clinically reviewed by Editorial Medical Review, MD, NAMS-CMP · Last updated 2026-05-25
How they work
Wegovy
Semaglutide formulated for weight management. Same GLP-1 receptor agonism as Ozempic but titrated to higher doses (up to 2.4 mg/week) — the dose shown in STEP trials to drive ~15% body weight reduction over 68 weeks.
Ozempic
Semaglutide formulated for glycemic control. Lower max dose (2 mg/week) targeted to A1c reduction in adults with type 2 diabetes. Off-label weight-loss use common, but insurance coverage typically denies without T2D diagnosis.
Available formulations
Wegovy
- Subcutaneous injection (single-dose pen), once weekly
- Doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg
- Indication: chronic weight management in adults and adolescents ≥12 with BMI ≥30 (or ≥27 with comorbidity)
Ozempic
- Subcutaneous injection (FlexTouch reusable pen), once weekly
- Doses: 0.25 mg, 0.5 mg, 1 mg, 2 mg
- Indication: type 2 diabetes mellitus + reduce risk of major cardiovascular events in T2D adults with established CV disease
Common questions(3)
Can I switch from Ozempic to Wegovy?
Yes — same active ingredient. Your clinician transitions the dose schedule. Insurance approval is the main hurdle: Wegovy requires obesity/overweight indication, Ozempic requires T2D. Some plans cover one but not the other.
Why is Wegovy more expensive than Ozempic?
Wegovy launched at a premium price ($1,349/month list) reflecting its weight-loss indication. Ozempic lists at $935/month. Both face shortages periodically. Compounded semaglutide is available at lower cash prices but is not FDA-approved.
Is Wegovy or Ozempic safer?
Safety profiles are identical at matched doses — same molecule. Both carry boxed warnings for thyroid C-cell tumors. The higher Wegovy doses (1.7-2.4 mg) cause more GI side effects on average. Neither is "safer" — the question is which dose matches your goal.
Sources(4)
Peer-reviewed and regulatory references. External links open in new tab.